by Ethan Webb | Aug 7, 2026 | Technology
New Medicare codes and the first commercial coverage give FDA-cleared prescription digital therapeutics the reimbursement they always lacked, including for substance use disorder. Key Takeaways Clearance was never the problem: Prescription digital therapeutics won FDA...
by Ethan Webb | Jul 23, 2026 | Regulation
Medicaid reentry waivers now let 19 states cover treatment before release, opening a new, federally funded market for SUD providers built around the highest-risk moment in recovery. Key Takeaways Reentry is a mortality crisis: People leaving incarceration face a...
by Ethan Webb | Jun 6, 2026 | Regulation
CMS’s interim final rule on Medicaid work requirements ties the serious mental illness and substance use disorder exemptions to a medically frail test built around the ability to work, and bars states from exempting people by diagnosis alone. Key Takeaways The...
